https://www.selleckchem.com/products/bms493.html
To evaluate the effect of 0.01% atropine eye drops on the ocular surface in children for the control of myopia. A total of 72 participants were recruited for this prospective study. Prior to and after 1, 3, and 6 months of 0.01% atropine administration, an ocular surface disease index (OSDI) questionnaire was obtained, Keratograph 5M was used for the measurement of the tear meniscus height (TMH), noninvasive keratographic tear film break-up time (NK-BUT, the first keratographic break-up time, [NK-BUT ] and the average keratographic break